Once-Daily, High-Concentration MMX Mesalamine in Active Ulcerative Colitis
To access this article, please choose from the options below
Supported by Shire Pharmaceuticals Inc.
PII: S0016-5085(06)02234-7
doi:10.1053/j.gastro.2006.10.011
© 2007 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Continuing Medical Education Exam 1: January 2007

